Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5CNS 3Thoracic 2Gynecologic 2Genitourinary 2Tumor-Agnostic 1Sarcoma 1Other neoplasm 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Lung Neoplasms 2Pleural Effusion, Malignant 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1167Cisplatin 889Pemetrexed 845pembrolizumab 622Paclitaxel 608Docetaxel 539Gemcitabine 428Radiotherapy 390Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 296durvalumab 264Drug Therapy 260osimertinib 236atezolizumab 224Radiosurgery 194Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 131Ipilimumab 129130-nm albumin-bound paclitaxel 124Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Spectrum Analysis × Thoracic × Clear all
NCT00601848 2020-11-24

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
9 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant

NCT03356743 2018-05-04

Spectrum Analysis in Ex-vivo Human Lungs

University Health Network, Toronto

Phase NA Completed
20 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡